Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Gross Profit of $24.21 million for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $24.21M | +6587.8% |
| 2024 | $362.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $12.91M | +97.1% | +13.0% |
| October 31, 2025 | $11.42M | +96.0% | +29.1% |
| July 31, 2025 | $8.85M | +110.7% | +35.2% |
| January 31, 2025 | $6.55M | — | +12.3% |
| October 31, 2024 | $5.83M | — | +38.8% |
| July 31, 2024 | $4.20M | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed an increase of +6587.8% in Gross Profit compared to the prior fiscal year.
- Over the 2024–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s gross profit has grown by 6587.8% (from $362.0 thousand to $24.21 million).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: